CN Patent

CN111320588B — 一种纯化Lesinurad的方法

Assigned to Shanghai Aobo Biomedical Co ltd · Expires 2024-02-09 · 2y expired

What this patent protects

本发明涉及一种纯化Lesinurad杂质的方法。所述方法通过下面的路线纯化，该方法操作简捷安全，收率良好，产品纯度高，有很好的经济效应，适宜工业生产。

USPTO Abstract

本发明涉及一种纯化Lesinurad杂质的方法。所述方法通过下面的路线纯化，该方法操作简捷安全，收率良好，产品纯度高，有很好的经济效应，适宜工业生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN111320588B
Jurisdiction
CN
Classification
—
Expires
2024-02-09
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Aobo Biomedical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.